Page last updated: 2024-10-20

pyridine and Disease Exacerbation

pyridine has been researched along with Disease Exacerbation in 1 studies

azine : An organonitrogen compound of general structure RCH=N-N=CHR or RR'C=N-N=CRR'.

Research Excerpts

ExcerptRelevanceReference
" Tumor growth inhibition was observed during the dosing interval, and the tumors regrew when compound administration was ceased."1.33Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo. ( Bouska, JJ; de Jong, R; Giranda, VL; Gramling-Evans, EE; Guan, R; Han, EK; Johnson, EF; Klinghofer, V; Leverson, JD; Li, Q; Li, T; Liu, X; Luo, Y; Mamo, M; McGonigal, TP; Mika, AK; Mitten, MJ; Nguyen, PT; Oleksijew, A; Oltersdorf, T; Powlas, JA; Rosenberg, SH; Shi, Y; Shoemaker, AR; Smith, RA; Stoll, VS; Thomas, SA; Woods, KW; Zinker, BA, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luo, Y1
Shoemaker, AR1
Liu, X1
Woods, KW1
Thomas, SA1
de Jong, R1
Han, EK1
Li, T1
Stoll, VS1
Powlas, JA1
Oleksijew, A1
Mitten, MJ1
Shi, Y1
Guan, R1
McGonigal, TP1
Klinghofer, V1
Johnson, EF1
Leverson, JD1
Bouska, JJ1
Mamo, M1
Smith, RA1
Gramling-Evans, EE1
Zinker, BA1
Mika, AK1
Nguyen, PT1
Oltersdorf, T1
Rosenberg, SH1
Li, Q1
Giranda, VL1

Other Studies

1 other study available for pyridine and Disease Exacerbation

ArticleYear
Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:6

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Progression; Humans; Indazoles; Indoles; M

2005